Respiratory News and Research

RSS

Study raises hope for reducing life-threatening respiratory problems in infants

St. Jude Children's Research Hospital scientists have a lead on reducing life-threatening respiratory problems in infants born to women who develop the liver disorder intrahepatic cholestasis of pregnancy (ICP).

30 Sep 2015

Spiolto Respimat shown to be superior first line therapy over LABA/ICS for COPD

Boehringer Ingelheim today announced new data from two trials presented at the European Respiratory Society (ERS) International Congress 2015

29 Sep 2015

Research posters support utility of EKF’s PointMan DNA enrichment technology for rapid detection of lung cancer mutations

EKF, announces two research posters supporting application of PointMan™ DNA enrichment technology, for rapid and sensitive detection of lung cancer mutations.

From EKF Diagnostics 29 Sep 2015

Philips showcases latest patient-driven sleep and respiratory solutions at the European Respiratory Society International Congress 2015

Philips Respironics, a business of Royal Philips, will showcase its latest portfolio of sleep-disordered breathing and respiratory solutions September 26-29 at the European Respiratory Society (ERS) International Congress 2015 in Amsterdam. At booth 1.H_01, Hall 1, clinicians can experience the latest Philips sleep-disordered breathing solutions and new options for COPD management that connect and support the patient, clinician and caregiver to improve patient care and help patients to live active lives.

From Philips Healthcare 28 Sep 2015

Air Liquide Healthcare launches a website dedicated to sleep apnea

On the occasion of the ERS's (European Respiratory Society) annual international seminar, which is held in Amsterdam from 27 to 30 September, Air Liquide Healthcare is launching an innovative and educational information website dedicated to sleep apnea.

28 Sep 2015

Teva presents new Reslizumab data at European Respiratory Society (ERS) International Congress 2015

Teva Pharmaceutical Industries Ltd., has presented results from a post hoc analysis of two pivotal Phase III clinical trials showing that treatment with reslizumab reduced clinical asthma exacerbations (CAEs) by 75 percent versus placebo in a subgroup of patients with late onset asthma (diagnosed at 40 years of age and older) with elevated blood eosinophils, who were inadequately controlled on inhaled corticosteroids (ICS).

28 Sep 2015

Occupational exposure to metalworking fluid associated with irreversible lung disease

Occupational exposure to fluid commonly used in metal machining operations may be related to a rare, irreversible lung disease, according to research presented at the European Respiratory Society's (ERS) International Congress today (28 September, 2015).

28 Sep 2015

Health effects of occupational exposure to talc

Talc, a substance commonly used in a number of manufacturing processes, including many in the food processing industry, is a health hazard and exposure to it should be closely monitored, say researchers from The Netherlands.

28 Sep 2015

Frequent infections in early life may increase risk factor for coeliac disease development in later life

Children with frequent infections in the first 18 months of life have a slightly increased risk of later developing coeliac disease compared with children who have few infections. This is the conclusion from a study by the Norwegian Institute of Public Health.

28 Sep 2015

Bioreactor Monitoring using Mass Spectrometry

Chuck DeCarlo provides advice on bioreactor monitoring using mass spectrometry and gives an introduction to the MAX300-BIO bioreactor gas analyzer.

From Extrel CMS, LLC 28 Sep 2015

UK Biobank genetic study shows link between lung disease and smoking behaviour

New research published in The Lancet Respiratory Medicine and presented at this year's European Respiratory Society meeting in Amsterdam presents the first analyses of genetic data from the UK Biobank that reveal new associations with lung disease and smoking behaviour.

28 Sep 2015

Walking to work through quieter side streets may reduce risk of exposure to peaks in harmful air pollution

Commuting to work by walking on quieter side streets rather than main roads can help people avoid exposure to peaks in harmful air pollution, according to new research presented today at the European Respiratory Society's International Congress, 2015.

28 Sep 2015

Interaction between rhinovirus and nasal microbiota in early life persists over time

The interaction between infections and the microbiota during infancy in the lungs could help provide clues to disease development later in life, according to the findings of a new study.

28 Sep 2015

Portuguese researchers find significant differences between smokers and non-smokers who develop NSCLC

Tobacco smoke is known to be the main risk factor for non-small cell lung cancer (NSCLC), although non-smokers can get it too. The incidence among non-smokers is increasing in many countries. Now a group of Portuguese researchers has found significant differences in clinical particularities and survival between smokers and non-smokers who develop NSCLC.

28 Sep 2015

Soft palate study reveals how flu viruses acquire the ability to move between people

National Institutes of Health scientists and their colleagues identified a previously unappreciated role for the soft palate during research to better understand how influenza (flu) viruses acquire the ability to move efficiently between people.

26 Sep 2015

Novo Nordisk announces FDA approval of Tresiba (insulin degludec injection) for diabetes treatment

Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration approved the new drug application for Tresiba (insulin degludec injection), a once-daily, long-acting basal insulin. Tresiba is indicated for use alone, or in combination with oral antidiabetic medicines or bolus insulin, and is approved for glycemic control in adults with type 1 and type 2 diabetes. Tresiba provides a long duration of action beyond 42 hours.

From Novo Nordisk 26 Sep 2015

Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)

"We are pleased to receive positive CHMP opinions for Kyprolis and BLINCYTO as this is an important step in providing new treatment options for patients in Europe with rare forms of cancer," said Sean E. Harper, M.D., executive vice president of Research and Development at Amgen.

25 Sep 2015

BD Life Sciences announces FDA clearance for BD MAX Enteric Parasite Panel

BD Life Sciences, a segment of global medical technology company BD (Becton, Dickinson and Company), today announced the availability of the U.S. Food and Drug Administration cleared BD MAX Enteric Parasite Panel for use on the BD MAX System.

From BD (Becton, Dickinson and Company) 24 Sep 2015

Premature infants in intensive care units exposed to a great deal of pain

Premature infants receiving intensive care are exposed to a great deal of pain, and this pain causes damage to the child. Despite this half of the infants admitted to neonatal intensive units will not receive any pain relief, according to a new European study published today in The Lancet Respiratory Medicine.

24 Sep 2015

Soft palate plays key role in viruses' ability to spread

Flu viruses come in many strains, and some are better equipped than others to spread from person to person. Scientists have now discovered that the soft palate -- the soft tissue at the back of the roof of the mouth -- plays a key role in viruses' ability to travel through the air from one person to another.

24 Sep 2015

Respiratory News and Research

Study raises hope for reducing life-threatening respiratory problems in infants

Spiolto Respimat shown to be superior first line therapy over LABA/ICS for COPD

Research posters support utility of EKF’s PointMan DNA enrichment technology for rapid detection of lung cancer mutations

Philips showcases latest patient-driven sleep and respiratory solutions at the European Respiratory Society International Congress 2015

Air Liquide Healthcare launches a website dedicated to sleep apnea

Teva presents new Reslizumab data at European Respiratory Society (ERS) International Congress 2015

Occupational exposure to metalworking fluid associated with irreversible lung disease

Health effects of occupational exposure to talc

Frequent infections in early life may increase risk factor for coeliac disease development in later life

Bioreactor Monitoring using Mass Spectrometry

UK Biobank genetic study shows link between lung disease and smoking behaviour

Walking to work through quieter side streets may reduce risk of exposure to peaks in harmful air pollution

Interaction between rhinovirus and nasal microbiota in early life persists over time

Portuguese researchers find significant differences between smokers and non-smokers who develop NSCLC

Soft palate study reveals how flu viruses acquire the ability to move between people

Novo Nordisk announces FDA approval of Tresiba (insulin degludec injection) for diabetes treatment

Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)

BD Life Sciences announces FDA clearance for BD MAX Enteric Parasite Panel

Premature infants in intensive care units exposed to a great deal of pain

Soft palate plays key role in viruses' ability to spread

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News